Hald SR 200 Tablet contains Progesterone (Natural Micronized) 200 mg, a synthetic form of the naturally occurring hormone progesterone. It is primarily indicated for hormone replacement therapy in women with progesterone deficiency, management of menstrual disorders, and support of luteal phase in assisted reproductive technology. Progesterone plays a critical role in regulating the menstrual cycle, maintaining pregnancy, and preparing the endometrium for implantation. Hald SR 200 is formulated as a sustained-release tablet to provide a controlled and prolonged release of progesterone, ensuring stable plasma levels and improved therapeutic efficacy. This medication is commonly prescribed for conditions such as amenorrhea, abnormal uterine bleeding due to hormonal imbalance, and prevention of endometrial hyperplasia in postmenopausal women receiving estrogen therapy. Additionally, it may be used in infertility treatment protocols to support early pregnancy. The tablet should be taken orally as directed by a healthcare professional, with dosage tailored to the individual’s clinical condition. Common side effects may include dizziness, headache, breast tenderness, and gastrointestinal disturbances. Contraindications include known hypersensitivity to progesterone, unexplained vaginal bleeding, and certain thromboembolic disorders. Regular monitoring by a healthcare provider is recommended during therapy to ensure safety and effectiveness.